Typhoid fever medical therapy

Typhoid fever Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Typhoid fever from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X ray
CT
MRI
Ultrasound
Other Imaging Findings
Other diagnostic tests
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Typhoid fever medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Typhoid fever medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Typhoid fever medical therapy
CDC on Typhoid fever medical therapy
Typhoid fever medical therapy in the news
Blogs on Typhoid fever medical therapy
Directions to Hospitals Treating Typhoid fever
Risk calculators and risk factors for Typhoid fever medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2] Aysha Anwar, M.B.B.S[3]

Overview

The mainstay of therapy for typhoid fever is antimicrobial therapy. Patients with uncomplicated typhoid fever are treated with either Azithromycin or a fluoroquinolone whereas patients with severe disease are treated with either Ceftriaxone, Cefotaxime, or a fluoroquinolone.

Medical therapy

Typhoid fever in most cases is not fatal. Antibiotics, such as ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, and ciprofloxacin, have been commonly used to treat typhoid fever in developed countries. Prompt treatment of the disease with antibiotics reduces the case-fatality rate to approximately 1%.

Resistance

Resistance to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole and streptomycin is now common, and these agents have not been used as first line treatment now for almost 20 years. Typhoid that is resistant to these agents is known as multidrug-resistant] typhoid (MDR typhoid).

Ciprofloxacin resistance is an increasing problem, especially in the Indian subcontinent and Southeast Asia. Many centres are therefore moving away from using ciprofloxacin as first line for treating suspected typhoid originating in India, Pakistan, Bangladesh, Thailand or Vietnam. For these patients, the recommended first line treatment is ceftriaxone.

There is a separate problem with laboratory testing for reduced susceptibility to ciprofloxacin: current recommendations are that isolates should be tested simultaneously against ciprofloxacin (CIP) and against nalidixic acid (NAL), and that isolates that are sensitive to both CIP and NAL should be reported as "sensitive to ciprofloxacin", but that isolates testing sensitive to CIP but not to NAL should be reported as "reduced sensitivity to ciprofloxacin". However, an analysis of 271 isolates showed that around 18% of isolates with a reduced susceptibility to ciprofloxacin (MIC 0.125–1.0 mg/l) would not be picked up by this method. It not certain how this problem can be solved, because most laboratories around the world (including the West) are dependent disc testing and cannot test for MICs.

Antimicrobial regimen

• Typhoid fever

• Uncomplicated typhoid

• Preferred regimen (1) (fully susceptible): Fluoroquinolone (e.g., Ofloxacin 15 mg/kg PO qd for 5–7 days)
• Preferred regimen (2) (multi drug-resistant): Fluoroquinolone (Ofloxacin 15 mg/kg PO qd for 5–7 days)
• Preferred regimen (3) (quinolone-resistant): Azithromycin 8–10 mg/kg PO qd for 7 days
• Preferred regimen (4) (quinolone-resistant): Fluoroquinolone 20 mg/kg PO qd for 10-14 days
• Alternative regimen (1) (fully susceptible): Chloramphenicol 50–75 mg/kg PO qd for 14-21 days
• Alternative regimen (2) (fully susceptible): Amoxicillin 75–100 mg/kg PO qd for 14 days
• Alternative regimen (3) (fully susceptible): Trimethoprim–Sulfamethoxazole, 8 mg/kg (trimethoprim)– 40 mg/kg (sulfamethoxazole) PO qd for 14 days
• Alternative regimen (4) (multi drug-resistant): Azithromycin 8–10 mg/kg PO for 7 days
• Alternative regimen (5) (multi drug-resistant): Third-generation cephalosporin, e.g., Cefixime 20 mg/kg PO qd for 7-14 days
• Alternative regimen (6) (quinolone-resistant): Third-generation cephalosporin, e.g., Cefixime 20 mg/kg PO qd for 7-14 days

• Severe typhoid

• Preferred regimen (1) (fully susceptible): Fluoroquinolone (e.g., Ofloxacin 15 mg/kg IV qd for 10-14 days)
• Preferred regimen (2) (multi drug-resistant): Fluoroquinolone (Ofloxacin 15 mg/kg IV qd for 10-14 days)
• Preferred regimen (3) (quinolone-resistant): Ceftriaxone 60 mg/kg IV qd for 10-14 days
• Preferred regimen (4) (quinolone-resistant): Cefotaxime 80 mg/kg IV qd for 10-14 days
• Alternative regimen (1) (fully susceptible): Chloramphenicol 100 mg/kg PO qd for 14-21 days
• Alternative regimen (2) (fully susceptible): Ampicillin 100 mg/kg PO qd for 14-21 days
• Alternative regimen (3) (fully susceptible): Trimethoprim–Sulfamethoxazole, 8 mg/kg (trimethoprim)– 40 mg/kg (sulfamethoxazole) IV qd for 10-14 days
• Alternative regimen (4) (multi drug-resistant): Ceftriaxone 60 mg/kg IV qd for 10-14 days
• Alternative regimen (5) (multi drug-resistant): Cefotaxime 80 mg/kg IV qd for 10-14 days
• Alternative regimen (6) (quinolone-resistant): Fluoroquinolone 20 mg/kg IV qd for 10-14 days

• 1. Uncomplicated typhoid fever

• 1.1 Fully sensitive

• Preferred regimen (1): Ofloxacin 15 mg/kg/day for 5-7 days

• Preferred regimen (2): Ciprofloxacin 15 mg/kg/day for 5-7 days
• Alternative regimen (1): Chloramphenicol 50-75 mg/kg/day for 14-21 days
• Alternative regimen (2): Amoxicillin 75-100 mg/kg/day for 14 days
• Alternative regimen (3): TMP-SMX 8-40 mg/kg/day for 14 days

• 1.2 Multidrug resistance

• Preferred regimen (1): Fluoroquinolone 15 mg/kg/day for 5-7 days

• Preferred regimen (2): Cefixime 15-20 mg/kg/day for 7-14 days
• Alternative regimen (1): Azithromycin 8-10 mg/kg/day for 7 days
• Alternative regimen (2): Cefixime 15-20 mg/kg/day for 7-14 days

• 1.3 Quinolone resistance

• Preferred regimen (1): Azithromycin 8-10 mg/kg/day for 7 days

• Preferred regimen (2): Ceftriaxone 75 mg/kg/day for 10-14 days
• Alternative regimen: Cefixime 20 mg/kg/day for 7-14 days

• 2. Severe typhoid fever

• 2.1 Fully sensitive

• Preferred regimen: Ofloxacin 15 mg/kg/day for 10-14 days
• Alternative regimen (1): Chloramphenicol 100 mg/kg/day for 14-21 days
• Alternative regimen (2): Amoxicillin 100 mg/kg/day for 14 days
• Alternative regimen (3): TMP-SMX 8-40 mg/kg/day for 14 days

• 2.2 Multidrug resistant

• Preferred regimen: Fluoroquinolone 15 mg/kg/day for 10-14 days
• Alternative regimen (1): Ceftriaxone 60 mg/kg/day for 10-14 days
• Alternative regimen (2): Cefotaxime 80 mg/kg/day for 10-14 days

• 2.3 Quinolone resistant

• Preferred regimen (1): Ceftriaxone 60 mg/kg/day for 10-14 days

• Preferred regimen (2): Cefotaxime 80 mg/kg/day for 10-14 days
• Alternative regimen: Fluoroquinolone 20 mg/kg/day for 7-14 days